DC4:FRA
Dexcom
50,40ย EUR
arrow_upward
+2,23%(+1,10) 1 ะดะฝ
30 ะบะฒัั., 22:00:00 GMT+2 · EUR
search
ะฃัั ัะธะผะฒะพะปะธ
1 ะดะฝ
5 ะดะฝ
1 ะผะปะฝ
6 ะผะปะฝ
ะ ะฟะพั. ั.
1 ั.
5 ั.
ะะฐะบั
| ะกะธะผะฒะพะป | ะฆัะฝะฐ | ะะผัะฝะฐ | % ะทะผัะฝะธ |
|---|
insights_autoะกัะฒะพัะตะฝะฝั ะฝะฐะนะฒะฐะถะปะธะฒััะพั ััะฐัะธััะธะบะธ ะดะปั DC4โฆ
ะัะดะบัะธัะธ
48,80ย EUR
ะะธัะพะบะฐ
50,60ย EUR
ะะธะทัะบะฐ
48,80ย EUR
ะ ะธะฝะบะพะฒะฐ ะบะฐะฟััะฐะปัะทะฐััั
23,67ย ะผะปัะด
ะกะตัะตะดะฝัะน ะพะฑััะณ
199,00
ะะฑััะณ
10,00
ะะฐะนะฒะธัะฐ ะทะฐ 52 ัะธะถะฝั
78,38ย EUR
ะะฐะนะฝะธะถัะฐ ะทะฐ 52 ัะธะถะฝั
46,88ย EUR
ะัะปัะบัััั ะฟัะฐััะฒะฝะธะบัะฒ
11ย ัะธั.
ะะพะฒะธะฝะธ
ะ ะดะถะตัะตะป ะฒ ะะฝัะตัะฝะตัั
Simply Wall Street
·
18 ะณะพะดะธะฝ ัะพะผั
DexCom (DXCM) Margin Improvement Challenges Cautious Narratives After Q1 2026 Earnings
Minichart
·
18 ะณะพะดะธะฝ ัะพะผั
Dexcom, Inc. Q1 2026 Financial Results: Strong Revenue, Earnings, and Forward-Looking Statements
Meyka
·
20 ะณะพะดะธะฝ ัะพะผั
DXCM DexCom Earnings Beat: Q1 2026 EPS Crushes Estimates
Seeking Alpha
·
1 ะดะตะฝั ัะพะผั
DexCom, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:DXCM) 2026-05-01
ะัะพััะปั
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
ะะฝัะพัะผะฐััั ะฟัะพ Dexcom
ะะตะฝะตัะฐะปัะฝะธะน ะดะธัะตะบัะพัะะตะฒัะฝ ะ . ะกะตัั
ะัะฐััะฒะฝะธะบะธ11ย ัะธั.
ะะฐัะฐ ะทะฐัะฝัะฒะฐะฝะฝั1999
ะะพะปะพะฒะฝะธะน ะพัััะกะฐะฝ-ะััะณะพ, ะะฐะปััะพัะฝัั, ะกะฟะพะปััะตะฝั ะจัะฐัะธ ะะผะตัะธะบะธ
ะะฐะปัะทั-
ะะตะฑัะฐะนัdexcom.com
ะกัะฒะพัะตะฝะธะน ะจะ ะบะพะฝัะตะฝั ะผะพะถะต ะผัััะธัะธ ะฟะพะผะธะปะบะธ. ะะพะบะปะฐะดะฝััะต
ะะพะฒัะดะบะฐะะฐะดััะปะฐัะธ ะฒัะดะณัะบะะพะฝััะดะตะฝััะนะฝััััะฃะผะพะฒะธะะฐััะตัะตะถะตะฝะฝั